Clem.com.au

Medical Articles
Clayton S, Clements CJ, Finch J. Time for Subtle Change. (Breast feeding practices).
Clayton S, Clements CJ, Finch J. Education for Infant Feeding in the School Setting.
Journal of Institute of Health Education 1980; 18:14-19.
Clayton S., Clements CJ, Finch J. Response and Initiatives: Breast Feeding in the Community. Midwives Chronicle 1980; 93:272-5.
Clayton S., Clements CJ., Finch J., Health Education and the School Curriculum: The Case for Infant Feeding. Health Ed. Journal 1981; 40:19-23 Clements CJ. Metronidazole and breast milk. NZ Medical Journal 1980; 92:329 Clayton S, Clements CJ, Finch J. Breast Feeding: Aiming for the Right Audience.
Maternal and Child Health 1981; 6: 237-40.
Clements CJ. Expression of breast milk. Midwives Chronicle 1982; 95:234-7.
Clements CJ. Community Medicine in UK: A lesson for New Zealand. New Zealand Clements CJ, Joseph J. Hearing Impairment: An outline of its Causes, Effects and Prevention. New Zealand Health Review 1981; 3:15-19 Clements CJ, Eskin F. Health Needs Hierarchy. New Zealand Health Review 1981; 4:2-5.
Flow Chart for Rubella Testing in Pregnancy and Infancy. Circular letter to Medical Practitioners PH 1/81 New Zealand Department of Health, April 1981.
Breast Feeding: How to express Your Milk. Parents Magazine 1982; 72:46-7.
Clements CJ. Childhood Assessments. Health 1981; 34:9-10.
Clements CJ. Diphtheria Immunity in New Zealand Children. New Zealand Medical Editorial. Life Style Diseases. New Zealand Health Review 1982; 2:2 Clements CJ, Health Education and Prevention in Relation to Alcohol Dependency. New Zealand Health Review 1982; 2:11-13.
Clements CJ, Establishing paediatric priorities in New Zealand. New Zealand Health Editorial. Child Health Report 1982. New Zealand Health Review 1982; 3:2 Clements CJ. Anthropometric Survey of Afghan Children. UNICEF, Kabul 1978. Also presented as MSc Dissertation. Manchester University 1980.
Clements CJ. Lower Immunization Rates in UK. New Zealand Medical Journal 1982; Clements CJ. Subtle Changes Needed in Breast Feeding Promotion. Parents Center Editorial. The Economics of community or hospital care. New Zealand Health Review Clements CJ. Seven articles on breast feeding. A General Setting; The Initial Choice: Are attitudes in the Antenatal Clinic Preconceived?; Subtle Changes are Needed;The Nurse and Advice-Giving; Continuing Successfully; Getting Home; Expressionof Breast milk. Department of Health, Wel ington, 1983.
Clements CJ. AIDS - The Facts. Health 1983; 35:3:3 Editorial. Funding of Health Services. New Zealand Health Review 1984;4:1:2.
Clements CJ. Polio Immunization: Live or Inactivated Vaccine. New Zealand Family Clements CJ. Hepatitis B. Health (New Zealand) 1984.
Clements CJ. Prevention of reaction to immunization. In Recording Child Health and Development: a handbook for professionals. Department of Health, Wellington1984; 145-6 Clements CJ. Influenza: the gentle correction or the giant killer? Health (New Zealand) Martin DR, Clements CJ. Scarlet fever. New Zealand Medical Journal. 1984; 97 (762): Editorial. Maori Health. New Zealand Health Review 1984; 6:2.
Clements CJ. Cocaine Country. Health (New Zealand) 1984; 36:4:14-55 Skegg DCG., Barham PM, Clements CJ, Fitzgerald NW, Paul C, Seddon RJ.
Recommendations for routine cervical screening. New Zealand Medical Journal1985; 98:636-639.
Clements CJ. AIDS - the end of permissive society? Health (New Zealand) 1985; 37 (1) Clements CJ, Tobias MJ. Rubel a testing and the new generation tests. Journal General Clements CJ. What do Community Physicians (New Zealand) do? New Zealand Health Editorial. A crisis in the service. New Zealand Health Review 1985; 5:3:2.
Clements CJ, Acquired immune deficiency syndrome (AIDS): an analysis of its arrival in New Zealand. New Zealand Family Physician 1985; 12:98-101.
Tobias M, Miller J, Clements CJ, Patel A. Hepatitis B in New Zealand children: the 1985 National Immunization Survey. New Zealand Medical Journal 1987; 100: 203-6.
Tobias M, Scadden J, Clements CJ, Patel A. Measles immunity in (New Zealand) children: the 1985 National Immunization Survey. New Zealand Medical Journal1987: 100: 315-7.
Clements CJ, Patel A.C, Pearce NE. New Zealand National Immunization Survey: methodology. New Zealand Medical Journal 1989; 102: 320-2.
Clements CJ. Chlamydia: a new look at an old disease. Health 1985; 37(3), 10-11.
Editorial. Vitamin A for measles. Lancet 1987; May 9: 1067-8.
Clements CJ.Immunization is not enough. (Immunization for travelers). World Health; von Reyn CF, Clements CJ, Mann JM. Human immuno-deficiency virus infection and routine childhood immunization. Lancet 1987, i , 669 - 72.
Clements CJ, von Reyn CF, Mann JM. HIV infection and routine childhood immunization: a review. Bul WHO, 65 (6): 905-911 (1987).
Progress in the control of viral hepatitis: Memorandum from a WHO Meeting.
(Participation as one of attendees in drafting article.) Bul WHO, 66 (4): 443-455 (1988).
Tobias MI, Miller JA, Clements CJ, Patel AC. The 1985 national immunisation survey: hepatitis A. N Z Med J 1988 Nov 9;101(857):771-2 Measles immunization before the age of nine months? A position statement by the Expanded Programme on Immunization of the World Health Organization. Lancet1988; i : 1356-7.
Henderson RH, Keja J, Hayden G, Galazka A, Clements J, Chan C. Immunizing the children of the world: progress and prospects. Bul WHO 1988; 66 (5): 535-543.
Aaby P, Clements CJ. Measles immunization research: a review. Bull WHO 67 (4): 443- Clements CJ, Henderson RH. Funding Health Services. International Journal of (Eng) Cutts FT, Henderson RH, Clements CJ, Chen RT, Patriarca PA. Principles of measles control. Bul WHO, 1991; 69: 1-7.
(Fr) Cutts FT, Henderson RH, Clements CJ, Chen RT, Patriarca PA. Principes de la lutte contre la rougeole. Bul WHO, 1991; 69: 155-162.
(Eng) Clements CJ, Kane M, Hu DJ, Kim-Farley R. Hepatitis B vaccine joins the fight against pandemic disease. World Health Forum 11(2); 165-169: 1990.
(Fr) Clements CJ, Kane M, Hu D, Kim Farley R. Le vaccin anti-hepatite B entre en guerre contre la maladies pandemique. WHO Forum 1990, 11(2): 177-180.
(Sp) Clements CJ, Kane M, Hu D, Kim Farley R. La vacuna contra la hepatits B: un nuevo frente contra las enfermedades pandemicas. Foro mundial de la salud 1990;11(2): 165-168.
Heggenhougen HK, Clements CJ. An anthropological perspective on the acceptability of immunization services. Scand J Infect Dis Suppl 76:20-31, 1990.
(Eng) Clements CJ, Silimperi,D. Immunizing the children of poverty. World Health, (Fr) Clements CJ, Silimperi D. Vacciner les enfants pauvres. Sante du Monde, 1991; Clements CJ and the EPI Team. The Expanded Programme on Immunization in the 1990s. In Immunization: the old and the new. Proceedings of the Second NationalImmunization Conference, Canberra, 27-29 May 1991. Public Health Assoc ofAustralia Inc., Canberra 1992.
Clements CJ, Strassburg M, Cutts FT, Torel C. The epidemiology of measles. World Health Statistics Quarterly 1992; 45: 285-291.
Bolotovsky VM, Grabowsky M, Clements CJ, Albrecht P, Brenner ER, Zargaryonts AI, Litvinov SK and Mikheyeva IV. Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Lennigrad-16 and Schwarz strains of measles vaccines. IntJ Epidem 1994; 23: 1069-1076.
Kim-Farley R, and the Expanded Programme on Immunization team. Global Immunization. Annu Rev Publ Health 1992. 13:223-37.
Kim-Farley RJ. and the Expanded Programme on Immunization team. EPI for the 1990s.
(Eng) Megan J, Robertson S, Clements CJ. Yellow fever: the global situation. Bull (Fr) Megan J, Robertson S, Clements CJ. Fievre jaune: situation mondiale. Bull de (Eng) Rosenthal SR, Clements CJ. Two-dose measles vaccination schedules. Bull (Sp) Rosenthal SR, Clements CJ. Calendarios de vacunacion antisarampianosa en dos dosis. Boletin de la oficina sanitaria Panamericana 1995; 117: 33-43.
Diaz-Ortega J-L, Forsey T, Clements CJ, Milstien J. The relationship between dose and response of standard measles vaccine. Biologicals (1994) 22, 35-44.
Clements CJ. Prevention and management of measles. ARI News April-July. 28; 2: Strategic Issues in Measles Research. European Commission Directorate General XII, Science Research and Development. November 18, 1993 Brussels. Participantand co-author.
Byass P, Adedeji MD, Mongdem JG, Zwandor AC, Brew-Graves SH, Clements CJ.
Assessment and possible control of endemic measles in urban Nigeria. J Pub HMedicine 1995; 17:2:140-145.
A Bellagio Consensus. In: Measles control - resetting the agenda. A report of the Children's Vaccine Initiative's ad hoc Committee on an Investment Strategy forMeasles Control. Bellagio, Italy. March 15-19, 1993. J Inf Diseases 1994; 170:S63-S64.
Anon. Global Programme for Vaccines of the World Health Organization. Role of mass campaigns in global measles control. Lancet 1994; 344: 174-5.
The pathogenic aspects of measles virus infection: Memorandum from a WHO meeting.
(As participant and contributing author). Bul WHO 1994, 72(2): 199-206.
Hussey GD, Clements CJ. Clinical problems in measles case management. Annals Measurement of overall and cause-specific mortality in infants and children: Memorandum from a WHO/UNICEF meeting. Bul WHO 1994, 72 (5): 707-713.
Clements CJ. Immunizing children in the developing world. New World Health 1995, 62- Kim-Farley R, Zoffmann H, and the Expanded Programme on Immunization Team.
Expanded Programme on Immunization of the World Health Organization: progressreport. Inf Dis Clin Pract, 1994; 3: 418-442.
Public Health control of hepatitis A: Memorandum from a WHO Meeting. (Participant and contributing author). Bul WHO 1995; 73(1): 15-20.
Clements CJ. Measles: prospects for elimination and eradication. Can J Inf Dis, 6 (C) (Eng) Clements CJ. Measles in cities. World Health 1:32-33, 1996.
(Fr) Clements CJ. La rougeole en milieu urbain. Santé du monde. 1:32-33,1996.
Clements CJ. Opportunities to immunize. Child Health Dialogue 1996, 2, 3-4.
Hussey GD, Clements CJ. Clinical problems in measles case management. Annals of Aylward RB, Clements CJ, Olivé J.M. The impact of immunization control activities on measles outbreaks in middle and low income countries. Int J Epidemiol 1997,26(3):-.
Cutts FT, Clements CJ, Bennett JV. Alternative routes of measles immunization: a review. Biologicals (1997) 25, 323-338.
(Eng) Biellik RJ, Clements CJ. Strategies for minimizing nosocomial measles transmission. WHO Bul (1997) Vol.75, (4) 367-375.
(Sp) Panam Salud Publica 1998, 4(5): 350-7.
Clements CJ. Vaccine controversies in measles: is there a need for a new measles vaccine? Symposium: "Measles - the neglected killer". Supplement to theAmerican Journal Of Tropical Medicine and Hygiene (1996) 55; 2: 75.
Clements CJ. Vitamin A and treatment of measles cases - industrialized countries need it too. Prevention and eradication of xerophthalmia. Sight and Life Newsletter2/1997, 23-27.
Clements CJ. Immunization: into the new mil ennium. New World Health 1997; 6-8.
(Eng) Bland J, Clements CJ. Protecting the world’s children: the story of WHO’s immunization programme. WHO Forum 1998;19 (2), 162-173.
(Fr) Bland J, Clements CJ. Protéger les enfants: historique du programme de vaccination de l’OMS. Forum Mondial de la Santé 1998; 19: 164-176.
Lee JW, Melgaard B, Clements CJ, Kane M et al. Autism, inflammatory bowel disease and MMR vaccine. Letter to the editor. Lancet 351; 905, 1998 Clements CJ. Vaccination against measles (letter). Child Health Dialogue 1998;10: 2.
Clements CJ. Immunization: the basic schedule. Child Health Dialogue, January-March Clements CJ. Prevention of childhood il ness. Editorial. Child Health Dialogue, January- Clements CJ, Evans G, Dittman S, Reeler AV. Vaccine safety concerns everyone.
Clements CJ. Thiomersal in vaccines. Correspondence. Lancet April 8, 2000. 355; Halsey NA, Clements CJ, Sommer A, West K, Moulton LH, Shankar AH, Santosham M.
Combining vitamin A distribution with EPI contacts. A report of the InternationalVitamin A Consultative Group (IVACG) Task Force. April 2000. ILSI ResearchFoundation, Washington DC.
Jodar L, Clements CJ, Duclos P, Milstien JB. Ensuring vaccine safety in immunization programmes – a WHO perspective. Vaccine 19 (2001) 1594-1605.
Kharabsheh S, Al Otoum H, Clements CJ, Abbas A, Khuri-Bulos N, Belbesi A, Gaafar T, Dellepiane N. Mass psychogenic illness following Td vaccine in Jordan. Bulletin ofthe WHO 2001. 79 (8); 764-770.
Clements CJ. Vaccine safety from a WHO perspective. 8th Annual Meeting of the European Society of Pharmacovigilance. Abstracts. September 21-23, 2000,Verona, Italy. Eds Giampaolo Velo and Roberto Leone. Elsevier 2000.
Clements CJ. Expanded Programme on Immunization: successes to date (Editorial).
Vaccines: Children and Practice 2001, vol 4, 2-3.
Clements CJ, Aguado MT, Jodar L. Technologies to improve immunization safety. Drug Duclos P, Clements CJ. Thiomersal: a debated vaccine preservative. Pp166-7. Pan American Health Organization Technical Advisory Group on Vaccine PreventableDiseases. XIV Meeting, Foz do Iguaçu, Parna, Brazil. PAHO, Washington, 2000.
Clements CJ, Ball LK, Ball R, Pratt RD. Thiomersal in vaccines - is removal necessary? Clements CJ. Letter from Geneva. Snow Fields (Newsletter of the Australasian Faculty Proteger les enfants: historique du programme de vaccination de l'OMS. Bland J, Clements J. Le Rotarien 2001. 576 (Aout 2001) 33-37.
Clements CJ, Ratzen S. Misled and confused? Telling the public about vaccine safety.
Journal of Medical Ethics 2002; 5: 27-29.
Moss WJ, Clements CJ, Halsey NA. Immunization of children at risk for infection with human immunodeficiency virus. Bulletin of the World Health Organization 2003,81(1), 61-70.
Clements CJ, Griffiths E. The global impact of vaccines containing aluminium adjuvants.
Clements CJ. What separates us? A reaction to September 11th. Snow's Field.
Quarterly newsletter of the Australasian Faculty of Public Health Medicine, Autumn2002, 1-2.
Clements CJ, Larsen G, Jodar L. Technologies that make vaccines safer. Vaccine in Clements CJ. Vaccination: current status of tuberculosis. Abstract: The immune system in protection and susceptibility to tuberculosis. Scuola Superiore D'Immunologia,Ruggero, Ceppel ini, Castel o di Baia, Bacoli, Napoli, Italy. September 12-15, 2002.
Clements CJ. Thiomersal - a barometer of public perception of vaccine safety. Snow's Field. Quarterly newsletter of the Australasian Faculty of Public Health Medicine,Autumn 2002, Spring 2002, 4.
Clements CJ. Vaccine safety and public opinion. Abstract BPP-BPS-2-4. Pharmacy and Pharmaceutical Sciences World Congress 2002. Nice, France. 31 August - 5September 2002.
Clements CJ. Mass psychogenic illness after vaccines. Drug Safety. 2003;26(9):599- Demicheli V, Rivetti A, Di Pietrantonj C, Clements CJ, Jefferson T. Hepatitis B vaccination and multiple sclerosis. Evidence from a systematic review. Journal ofViral Hepatitis. 2003 Sep;10(5):343-4.
Clements CJ, Abdool-Karim Q, Nkowane B, Chang M-L, Esparza J. Breaking new ground - are there imminent changes in immunization services driven by theintroduction of HIV/AIDS vaccines? Vaccine (in press)

Source: http://www.clem.com.au/john/pdfs_old/articles.pdf

P. rafael braun, 4ta conferencia

El desarrollo de las personas como herramienta de gestión Las reflexiones que deseo proponerles toman en cuenta el valioso contenido del documento publicado por UNIAPAC: “La rentabilidad de los valores. Una vision cristiana de la Responsabilidad Social Empresarial.” Puesto que “estrictamente hablando, la “Responsabilidad” puede ser solamente aplicada a las personas, y no a cualquie

rd-pharma.mc

PROSOFT® extrait sec hydroalcoolique de millepertuis 300 mg Médicament à base de plante pour le traitement à court terme des symptômes dépressifs légers. Hypersensibilité au millepertuis ou à l’un des excipients contenu dans ®, comprimé enrobé  2. COMPOSITION QUALITATIVE ET QUANTITATIVEMillepertuis ( Hypericum perforatum L.) (extrait sec de sommité fleurie

Copyright © 2008-2018 All About Drugs